From Insight to Lasting Change: How To Support Your Client That Is Receiving Ketamine or Spravato Treatment
Description
Ketamine and Spravato are increasingly becoming a treatment option sought out by clients for their mental health, specifically for severe depression, anxiety, and PTSD. Clients are turning to their mental health professional, or seeking out a mental health professional, to help them get the most out of their ketamine or Spravato treatment & process the material that their treatment unearths for them — they are seeking what we in the field call ”integration.” This webinar will equip you with the knowledge needed to support clients in their ketamine and Spravato treatment - the knowledge of impactful, effective integration work - and will leave you feeling confident in doing so.
Learning Objectives
- At the end of this course, participants will be able to describe the purpose of integration following
ketamine and Spravato treatment. - At the end of this course, participants will be able to recognize common psychological experiences
that emerge during treatment. - At the end of this course, participants will be able to utilize evidence-informed integration
interventions to help clients translate insights into meaningful behavioral change. - At the end of this course, participants will be able to recognize clinical situations that warrant
consultation or collaboration with the prescribing medical team
Instructor Bio
Rena Beyer, MSW, LCSW is a psychotherapist, speaker, and founder of Fostering Greatness, a private practice specializing in ketamine-assisted psychotherapy (KAP), Spravato-assisted psychotherapy (SAP), trauma, depression, anxiety, and stress/overwhelm. Licensed in New Jersey, Pennsylvania, and Delaware, she has been working in the ketamine treatment space since 2017 and was the first psychotherapist on the East Coast to provide KAP.
Rena completed advanced training in ketamine-, MDMA-, and psilocybin-assisted therapies through the Integrative Psychiatry Institute and Polaris Insight Center. She is a former board member of the American Society of Ketamine Physicians, psychotherapists, and Practitioners, where she founded the Therapist Advisory Panel, and a former board member of the New Jersey Psychedelic Therapy Association. She provides CE-approved training for therapists on ketamine-assisted psychotherapy (KAP) and speaks nationally on KAP, SAP, psychedelic-assisted therapies, trauma-informed care, and innovative mental health
treatment approaches.
The instructor does not have any conflicts of interest for this webinar.
Contact Us
For questions, please contact: ce@gsapp.rutgers.edu
Continuing Education Policy:
Rutgers Graduate School of Applied and Professional Psychology (GSAPP) is recognized by the New York State Education Department's State Board for Psychology as an approved provider of continuing education for licensed psychologists #PSY-0123.
Rutgers Graduate School of Applied & Professional Psychology is approved by the American Psychological Association to sponsor continuing education for psychologists. Rutgers Graduate School of Applied & Professional Psychology maintains responsibility for this program and its content.
Rutgers Graduate School of Applied and Professional Psychology has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 8145. Programs that do not qualify for NBCC credit are clearly identified. Rutgers Graduate School of Applied and Professional Psychology is solely responsible for all aspects of the programs.